News & Features

The world of MS information changes rapidly. Breakthroughs in understanding the mechanisms of MS, its cause, and its treatment come at a rapid pace. And there's so much to know just about managing the disease in your daily life! 

To keep you informed and up-to-date, MS Focus offers informative periodicals and round-the-clock multimedia broadcasting. Whether print or digital, these materials are designed to be easy to understand for MS patients, their families, and care providers. Subscriptions are free of charge.

Study: Stem cell treatment can slow, stop MS for up to five years

February 23, 2017

A new study suggests stem cell therapy can slow or stop progression of multiple sclerosis for many years, and the treatment is most effective in people with MS who have 'active inflammation' in their brain and spinal cord.
Learn more

New study finds chronic demyelination, seizure link

February 22, 2017

A new mouse model study helps explain why some patients with multiple sclerosis have seizures. The findings could lead to the development of drugs aimed at reducing seizures in MS.
Learn more

TouchNEUROLOGY makes in-demand Vitamin D resources available online

February 17, 2017

TouchNEUROLOGY, together with the Consortium of MS Centers, have released summaries of a pair of in-demand scientific articles focused on vitamin D and MS. These summaries, which are intended for lay readers, are now available online.
Learn more

Researchers: Fingolimod may help with secondary progressive MS

February 09, 2017

Researchers: Fingolimod interferes with signals sent by lipid receptors, and may reduce the disease-producing activities by cells in the nervous system. The findings suggest the treatment may help difficult-to-treat secondary progressive MS.
Learn more

Researchers say they have found MS blood biomarker

February 06, 2017

A study by researchers at Macquarie University, in Sydney, Australia, claims to have found the first blood biomarker for multiple sclerosis.
Learn more

Ocrelizumab shown to be effective in both progressive, relapsing MS

January 12, 2017

Clinical trials show ocrelizumab can reduce new attacks in patients with relapsing MS, slow symptom progression in primary progressive MS
Learn more

21st Century Cures Act Passes U.S. Senate

December 08, 2016

New legislation contains an important provision for those affected by multiple sclerosis and other neurological diseases.
Learn more

Study suggests MS drug may reverse some physical disability

October 20, 2016

A drug used to treat multiple sclerosis, alemtuzumab, was found to reverse some of the physical disability caused by the disease.
Learn more

New research strengthens genetics, MS link

October 19, 2016

n a large-scale, genome-wide analysis of more than 110,000 samples, researchers identified 200 genetic loci associated with multiple sclerosis.
Learn more

Study: Stem cell treatment can slow, stop MS for up to five years

February 23, 2017

A new study suggests stem cell therapy can slow or stop progression of multiple sclerosis for many years, and the treatment is most effective in people with MS who have 'active inflammation' in their brain and spinal cord.
Learn more

New study finds chronic demyelination, seizure link

February 22, 2017

A new mouse model study helps explain why some patients with multiple sclerosis have seizures. The findings could lead to the development of drugs aimed at reducing seizures in MS.
Learn more

TouchNEUROLOGY makes in-demand Vitamin D resources available online

February 17, 2017

TouchNEUROLOGY, together with the Consortium of MS Centers, have released summaries of a pair of in-demand scientific articles focused on vitamin D and MS. These summaries, which are intended for lay readers, are now available online.
Learn more

Researchers: Fingolimod may help with secondary progressive MS

February 09, 2017

Researchers: Fingolimod interferes with signals sent by lipid receptors, and may reduce the disease-producing activities by cells in the nervous system. The findings suggest the treatment may help difficult-to-treat secondary progressive MS.
Learn more

Researchers say they have found MS blood biomarker

February 06, 2017

A study by researchers at Macquarie University, in Sydney, Australia, claims to have found the first blood biomarker for multiple sclerosis.
Learn more

Ocrelizumab shown to be effective in both progressive, relapsing MS

January 12, 2017

Clinical trials show ocrelizumab can reduce new attacks in patients with relapsing MS, slow symptom progression in primary progressive MS
Learn more

21st Century Cures Act Passes U.S. Senate

December 08, 2016

New legislation contains an important provision for those affected by multiple sclerosis and other neurological diseases.
Learn more

Study suggests MS drug may reverse some physical disability

October 20, 2016

A drug used to treat multiple sclerosis, alemtuzumab, was found to reverse some of the physical disability caused by the disease.
Learn more

New research strengthens genetics, MS link

October 19, 2016

n a large-scale, genome-wide analysis of more than 110,000 samples, researchers identified 200 genetic loci associated with multiple sclerosis.
Learn more

Improper criteria use can lead to MS misdiagnosis

September 12, 2016

Clinicians and researchers have known for decades that multiple sclerosis misdiagnosis is a problem. Authors of a new study define possible reasons why they are misdiagnosed.
Learn more

CVS Caremark to remove three MS drugs from 2017 formulary

August 29, 2016

CVS Caremark recently announced that it will remove three MS drugs, Avonex, Plegridy, and Extavia from its formulary at the start of the new year.
Learn more

Study suggests antibody may have therapeutic effect on MS

July 21, 2016

Researchers have developed an antibody with potential therapeutic effects against multiple sclerosis that opens up a new strategy for controlling the disease.
Learn more

Researchers find gut bacteria, MS link

July 13, 2016

In a new study, researchers detected clear evidence of changes that tie together bacteria living in the gut and immunological disorders such as multiple sclerosis
Learn more

Study finds hippocampus inflammation, depression link

July 08, 2016

A new study suggests that inflammation of the hippocampus – a region of the brain implicated in the genesis and maintenance of depression and in the pathology of multiple sclerosis – could be the contributing cause of high rates of depression in MS.
Learn more

New study suggests MS risk, obesity link

July 01, 2016

A new study suggests that elevated body mass index could be an important, and potentially modifiable, risk factor for multiple sclerosis.
Learn more

FDA grants Priority Review for ocrelizumab

June 29, 2016

Ocrevus would be the first and only treatment indicated for both forms of MS, which affect approximately 95 percent of people at diagnosis.
Learn more

Researchers image neuroinflammation in MS mouse model

June 24, 2016

Molecular imaging is bringing researchers closer to identifying autoimmune inflammation triggers in multiple sclerosis while providing a means of evaluating next-generation therapies for MS
Learn more

New study links four genes to MS

June 22, 2016

Researchers have identified four new risk genes that are altered in German patients with multiple sclerosis.
Learn more


Show More News